Welcome to LookChem.com Sign In|Join Free

CAS

  • or

52025-34-0

Post Buying Request

52025-34-0 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

52025-34-0 Usage

Uses

5-Amino-2-ethoxypyridine is a useful research reagent for the preparation of primaquine and primaquine analogs for the treatment of malarial.

Check Digit Verification of cas no

The CAS Registry Mumber 52025-34-0 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 5,2,0,2 and 5 respectively; the second part has 2 digits, 3 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 52025-34:
(7*5)+(6*2)+(5*0)+(4*2)+(3*5)+(2*3)+(1*4)=80
80 % 10 = 0
So 52025-34-0 is a valid CAS Registry Number.

52025-34-0SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 17, 2017

Revision Date: Aug 17, 2017

1.Identification

1.1 GHS Product identifier

Product name 5-Amino-2-ethoxypyridine

1.2 Other means of identification

Product number -
Other names 6-ethoxypyridin-3-amine

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:52025-34-0 SDS

52025-34-0Relevant articles and documents

SUBSTITUTED-3-CYANO-[1.7],[1.5], AND [1.8]-NAPHTHYRIDINE INHIBITORS OF TYROSINE KINASES

-

Page 49, (2010/02/06)

This invention provides compounds of formula (I) having structure (a) wherein A'' is a diavalent moiety selected from the group (a, b, c) which are useful as inhibitors of protein tyrosine kinase.

Synthesis and Purification of 6-Ethoxy-4-oxo-1,4-dihydro-[1,5] naphthyridine-3-carboxylic Acid Benzylamide

Beaudin, Justin,Meltz, Clifford N.,Meltz, Morgan,Phillips, James E.,Ragan, John A.,Brown Ripin, David H.,Singer, Robert A.,Tucker, John L.,Wei, Lulin,Bourassa, Dennis E.,Bowles, Paul,Castaldi, Michael J.,Clay, Ronald,Couturier, Michel A.,Karrick, Gregory,Makowski, Teresa W.,McDermott, Ruth E.

, p. 873 - 878 (2013/09/05)

The synthesis of 6-ethoxy-4-oxo-1,4-dihydro-[1,5]naphthyridine-3- carboxylic acid benzylamide (1) on multikilogram scale is described. The major challenge for the synthesis of this quinolone GABA partial agonist was in the isolation of product of acceptable purity for clinical studies due to the insolubility of this compound. Also described are efforts to circumvent a high-temperature cyclization required for the synthesis of the quinolone ring system.

Substituted 4-oxo-napthyridine-3-carboxamides: GABA brain receptor ligands

-

, (2008/06/13)

The present invention encompasses structures of the Formula or the pharmaceutically acceptable non-toxic salts thereof wherein: x is hydrogen, halogen, (un)substituted alkyl, (un)substituted alkoxy or amino; and Y is (un)substituted alkyl, aryl, or heteroaryl, which compounds are highly selective agonists, antagonists or inverse agonists for GABAa brain receptors or prodrugs of agonists, antagonists or inverse agonists for GABAa brain receptors. These compounds are useful in the diagnosis and treatment of anxiety, Down Syndrome, sleep, cognitive and seizure disorders, and overdose with benzodiazepine drugs and for enhancement of alertness.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 52025-34-0